News

Italian-based Stevanato Group, a leading producer of pharmaceutical glass containers and provider of integrated capabilities for drug delivery systems, has officially inaugurated its Technology Excellence Center (TEC) in Boston, Massachusetts. The new Center provides a full-service approach to support biopharma...

ChargePoint Technology, specialists in contained and sterile powder transfer solutions, has further strengthened its leadership team with the appointment of Emma Stoddart as Chief Financial Officer. Having been a partner at Grant Thornton where she spent over 20 years of...

Durbin, part of Uniphar Group, has been appointed to design and implement a global Early Access Program (EAP) on behalf of Jazz Pharmaceuticals plc for a new medicine containing the active substance, solriamfetol, and known commercially as Sunosi®. The therapy...

A £1 million crowdfunding campaign launched by PHARMASEAL to revolutionise global clinical trials and vaccine development has reached the next campaign milestone. Launched by the new provider of clinical trial management and governance solutions last month, the campaign is aimed...

Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro...

Following accelerated levels of growth over the last six months, Raremark®, the leading rare disease patient network and real-world insights provider has reasserted its commitment to patient-centric drug development by implementing a new, dynamic executive team to drive the...

Swedish life science company, Sobrera Pharma, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development and manufacturing of SO-001, a new oral treatment for Alcohol Use Disorder (AUD). A phase II...